etrials Worldwide (Morrisville, North Carolina), a provider of adaptive eClinical software and services that optimize clinical trial management, said that its board of directors has retained Emerging Growth Equities (EGE) as its exclusive financial advisor to assist in evaluating strategic or other alternatives with a focus on acquisitions that may be available to the company.

"With a strong balance sheet and a comprehensive product offering of integrated eClinical solutions, we feel strongly that the time is right to engage EGE to assist the company in enhancing shareholder value and advancing the company's overall growth strategy," said Robert Brill, etrials' chairman. "EGE's expertise and experience in the healthcare IT sector positions the firm to evaluate, advise and guide us through opportunities that are intended to result in greater value to our customers and our shareholders."

No Comments